Incyte has agreed to acquire Vega Therapeutics for up to $2 billion, the companies said, in a deal designed to bolster the buyer’s hematology pipeline with antibody assets led by VGA039, a Phase III ...

Interim trial results showed vaccine to be safe and induced immune responses against Lassa virus and rabies virus.

A complete wiring diagram of all the connections between the fruit fly brain and "spinal cord" provides translational ...

ACT-CHIK, a project led by Institut Pasteur, will advance chikungunya vaccine trials across four African countries.

Antiretroviral therapy (ART) has enabled most people living with HIV to live long and healthy lives. However, a small portion of people experience detectable traces of the virus, known as ...

The scientists found that administering the adjuvant with the vaccine yielded a two-fold increase in gut mucosal antibodies.

AI hallucinations pose particular risks in biotechnology-related legal matters because cases often depend on highly technical evidence.

The combined solutions support characterization capabilities for antibodies that cannot be achieved using standalone methods.

Support for screening does not depend on any one view of AI; the biosecurity case has long been recognized by scientists and ...

Mid-cap buyers, improved capital raising climate, and reshoring of manufacturing are shaping how much and where biopharmas ...

According to the World Health Organization’s Global Status Report on Neurology, over 40% of the global population is living ...

D&D‑seq uses base editing to record DNA–protein interactions in single cells, enabling multiomics mapping of transcription ...